266 related articles for article (PubMed ID: 37535899)
1. The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology.
Ye Z; Harmon J; Ni W; Li Y; Wich D; Xu Q
ACS Nano; 2023 Aug; 17(16):15231-15253. PubMed ID: 37535899
[TBL] [Abstract][Full Text] [Related]
2. Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach.
Bhattacharya M; Sharma AR; Ghosh P; Patra P; Patra BC; Lee SS; Chakraborty C
Mol Biotechnol; 2022 May; 64(5):510-525. PubMed ID: 34981440
[TBL] [Abstract][Full Text] [Related]
3. Advances of Reverse Vaccinology for mRNA Vaccine Design against SARS-CoV-2: A Review of Methods and Tools.
da Silva MK; Campos DMO; Akash S; Akter S; Yee LC; Fulco UL; Oliveira JIN
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896907
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 mRNA vaccines: Platforms and current developments.
Szabó GT; Mahiny AJ; Vlatkovic I
Mol Ther; 2022 May; 30(5):1850-1868. PubMed ID: 35189345
[TBL] [Abstract][Full Text] [Related]
5. Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited].
Jawalagatti V; Kirthika P; Lee JH
Front Immunol; 2022; 13():884862. PubMed ID: 35592330
[TBL] [Abstract][Full Text] [Related]
6. mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic.
Xu Z; Fisher DE
Front Immunol; 2023; 14():1155728. PubMed ID: 37063845
[TBL] [Abstract][Full Text] [Related]
7. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
Deng Z; Tian Y; Song J; An G; Yang P
Front Immunol; 2022; 13():887125. PubMed ID: 35720301
[TBL] [Abstract][Full Text] [Related]
8. mRNA vaccines for COVID-19 and diverse diseases.
Hussain A; Yang H; Zhang M; Liu Q; Alotaibi G; Irfan M; He H; Chang J; Liang XJ; Weng Y; Huang Y
J Control Release; 2022 May; 345():314-333. PubMed ID: 35331783
[TBL] [Abstract][Full Text] [Related]
9. Trans-Amplifying RNA Vaccines Against Infectious Diseases: A Comparison with Non-Replicating and Self-Amplifying RNA.
Zimmermann L; Erbar S
Methods Mol Biol; 2024; 2786():135-144. PubMed ID: 38814392
[TBL] [Abstract][Full Text] [Related]
10. Race with virus evolution: The development and application of mRNA vaccines against SARS-CoV-2.
Lee KM; Lin SJ; Wu CJ; Kuo RL
Biomed J; 2023 Feb; 46(1):70-80. PubMed ID: 36642222
[TBL] [Abstract][Full Text] [Related]
11. Advances in COVID-19 mRNA vaccine development.
Fang E; Liu X; Li M; Zhang Z; Song L; Zhu B; Wu X; Liu J; Zhao D; Li Y
Signal Transduct Target Ther; 2022 Mar; 7(1):94. PubMed ID: 35322018
[TBL] [Abstract][Full Text] [Related]
12. mRNA vaccines for infectious diseases: principles, delivery and clinical translation.
Chaudhary N; Weissman D; Whitehead KA
Nat Rev Drug Discov; 2021 Nov; 20(11):817-838. PubMed ID: 34433919
[TBL] [Abstract][Full Text] [Related]
13. Vaccines' New Era-RNA Vaccine.
Zhou W; Jiang L; Liao S; Wu F; Yang G; Hou L; Liu L; Pan X; Jia W; Zhang Y
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632102
[TBL] [Abstract][Full Text] [Related]
14. Introduction to RNA Vaccines Post COVID-19.
Kramps T
Methods Mol Biol; 2024; 2786():1-22. PubMed ID: 38814388
[TBL] [Abstract][Full Text] [Related]
15. Advances in mRNA vaccines.
Li M; Wang Z; Xie C; Xia X
Int Rev Cell Mol Biol; 2022; 372():295-316. PubMed ID: 36064266
[TBL] [Abstract][Full Text] [Related]
16. Paving the Way Towards Precision Vaccinology: The Paradigm of Myocarditis After Coronavirus Disease 2019 (COVID-19) Vaccination.
Lagousi T; Papadatou I; Strempas P; Chatzikalil E; Spoulou V
Clin Infect Dis; 2022 Aug; 75(Suppl 1):S18-S23. PubMed ID: 35607748
[TBL] [Abstract][Full Text] [Related]
17. Vaccines on demand, part II: future reality.
Geall AJ; Kis Z; Ulmer JB
Expert Opin Drug Discov; 2023 Feb; 18(2):119-127. PubMed ID: 36384351
[TBL] [Abstract][Full Text] [Related]
18. mRNA Vaccines in the COVID-19 Pandemic and Beyond.
Hogan MJ; Pardi N
Annu Rev Med; 2022 Jan; 73():17-39. PubMed ID: 34669432
[TBL] [Abstract][Full Text] [Related]
19. An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations.
Mirtaleb MS; Falak R; Heshmatnia J; Bakhshandeh B; Taheri RA; Soleimanjahi H; Zolfaghari Emameh R
Int Immunopharmacol; 2023 Apr; 117():109934. PubMed ID: 36867924
[TBL] [Abstract][Full Text] [Related]
20. Research progress on the quality control of mRNA vaccines.
Hu C; Bai Y; Liu J; Wang Y; He Q; Zhang X; Cheng F; Xu M; Mao Q; Liang Z
Expert Rev Vaccines; 2024; 23(1):570-583. PubMed ID: 38733272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
